SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Intuitive Surgical, Inc. (ISRG) trades at a trailing P/E of 56.6, forward P/E of 46.8. Trailing earnings yield is 1.77%, forward earnings yield 2.14%. PEG 2.51. Graham Number is $95.67.
Criteria proven by this page:
- VALUE (31/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 56.6); PEG > 2.0 means the stock is expensive even after accounting for growth (PEG 2.51).
- Forward P/E 46.8 (down from trailing 56.6) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 2.51 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 1.77% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 2.14% as earnings recover.
- Analyst consensus target $638.75 (+36.7% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 81/100 with 6/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
31/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ISRG
Valuation Multiples
P/E (TTM)56.6
Forward P/E46.8
PEG Ratio2.51
Forward PEG1.73
P/B Ratio9.08
P/S Ratio16.08
EV/EBITDA43.8
Per Share Data
EPS (TTM)$8.05
Forward EPS (Est.)$9.99
Book Value / Share$50.55
Revenue / Share$28.36
FCF / Share$7.02
Yields & Fair Value
Earnings Yield1.77%
Forward Earnings Yield2.14%
Dividend Yield0.00%
Graham Number$95.67
SharesGrow IV$259.27 (-44.5%)
Analyst Target$638.75 (+36.7%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
33.0 |
1.57 |
4.20 |
8.98 |
- |
| 2017 |
61.8 |
-8.22 |
8.62 |
13.03 |
- |
| 2018 |
48.3 |
0.71 |
8.15 |
14.62 |
- |
| 2019 |
49.5 |
2.44 |
8.23 |
15.23 |
- |
| 2020 |
90.2 |
-3.74 |
9.81 |
21.96 |
- |
| 2021 |
75.1 |
1.28 |
10.71 |
22.41 |
- |
| 2022 |
71.4 |
-3.20 |
8.55 |
15.17 |
- |
| 2023 |
65.9 |
1.75 |
8.90 |
16.63 |
- |
| 2024 |
79.8 |
2.88 |
11.28 |
22.20 |
- |
| 2025 |
70.8 |
3.17 |
11.34 |
20.08 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.08 |
$2.7B |
$735.9M |
27.2% |
| 2017 |
$1.89 |
$3.13B |
$660M |
21.1% |
| 2018 |
$3.16 |
$3.72B |
$1.13B |
30.3% |
| 2019 |
$3.85 |
$4.48B |
$1.38B |
30.8% |
| 2020 |
$2.94 |
$4.36B |
$1.06B |
24.3% |
| 2021 |
$4.66 |
$5.71B |
$1.7B |
29.9% |
| 2022 |
$3.65 |
$6.22B |
$1.32B |
21.3% |
| 2023 |
$5.03 |
$7.12B |
$1.8B |
25.2% |
| 2024 |
$6.42 |
$8.35B |
$2.32B |
27.8% |
| 2025 |
$7.87 |
$10.06B |
$2.86B |
28.4% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$10.01 |
$9.66 – $11.18 |
$11.52B |
$11.17B – $12.36B |
18 |
| 2027 |
$11.42 |
$11.05 – $12.26 |
$13.11B |
$12.48B – $13.51B |
17 |
| 2028 |
$13.10 |
$12.18 – $14.19 |
$14.97B |
$14.91B – $15.03B |
7 |
| 2029 |
$15.13 |
$14.28 – $16.25 |
$17.23B |
$16.48B – $18.2B |
2 |
| 2030 |
$16.55 |
$15.61 – $17.77 |
$18.89B |
$18.07B – $19.96B |
5 |
